San Antonio – The first round of people who took part in a COVID-19 vaccine trial in South Texas was given a dose on Thursday.
The double blind Pfizer trial is different from a vaccine trial conducted by Moderna, which begins on Friday after being delayed for a few days.
“I am the biggest health threat of my life, because I cannot think of more important clinical trials than this one, because I am Stephen Davis, one of the first participants in the Pfizer trial.” “I have a great faith in clinical trials. We conduct clinical trials, at our own practice. And if it weren’t for clinical trials, we wouldn’t have things like the polio vaccine. “
However, the trial is a double blind study and Davis is not sure whether he, his wife or son will be given the actual vaccine or placebo, saying he is happy to be given the opportunity to participate.
“They want to test people who are over 65. Both me and my wife are over 65. They want to test people who are directly involved in health care. Davis said, me and my son, Those working in my office are both directly involved in health care.
Texas Biotech Facility at College Station Tapped Large-Scale Potential COVID-19 Vaccine
To participate in the Pfizer trial, you must be 18 years or older and call the Clinical Trials of Texas, lab hosting the study, to be screened.
“We want to know and try to determine … if they have a disease or condition, is it under control? We want to know what drugs they work on,” said CTT CEO Kaya Scroggins. are doing.
Like other tests, researchers assure participants that they cannot become infected with coronovirus by reviving the Pfizer vaccine, which does not survive.
“It’s a particle of the virus. And so when the virus is administered, it will expect an immune response,” Scroggins said.
If the test is successful and everyone is employed, the Pfizer vaccine may be available to people as early as next year.
UK scientists vaccinate hundreds with coronavirus vaccine
The Texas clinical trial is looking at screening thousands more people to participate in a two-year Pfizer study as well as at least two other COVID-19 vaccine trial studies that are expected to close in the next few months.
For more information call 210-949-0122 or click here.
Copyright 2020 by KSAT – All rights reserved.